Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

REALMUTO, Sabrina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.600
EU - Europa 2.669
AS - Asia 949
AF - Africa 52
OC - Oceania 17
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 12
Totale 8.313
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.569
IT - Italia 1.096
FI - Finlandia 532
CN - Cina 487
SG - Singapore 251
IE - Irlanda 225
UA - Ucraina 142
DE - Germania 138
GB - Regno Unito 115
BE - Belgio 79
RU - Federazione Russa 76
KR - Corea 65
FR - Francia 62
IR - Iran 52
SE - Svezia 37
RO - Romania 34
NL - Olanda 31
IN - India 30
PL - Polonia 29
EG - Egitto 27
CI - Costa d'Avorio 22
CA - Canada 21
ES - Italia 20
AU - Australia 15
CZ - Repubblica Ceca 15
TR - Turchia 15
HK - Hong Kong 13
JP - Giappone 12
BR - Brasile 11
EU - Europa 10
HN - Honduras 8
AT - Austria 7
ID - Indonesia 7
CH - Svizzera 5
GR - Grecia 5
HU - Ungheria 4
MD - Moldavia 4
TW - Taiwan 4
UZ - Uzbekistan 4
NG - Nigeria 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DK - Danimarca 2
MX - Messico 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
PT - Portogallo 2
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
GE - Georgia 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
LT - Lituania 1
NP - Nepal 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 8.313
Salva come PNG Salva come JPEG
Città #
Fairfield 517
Chandler 444
Ashburn 442
Woodbridge 307
Ann Arbor 292
Wilmington 256
Houston 234
Seattle 229
Dublin 225
Singapore 200
Cambridge 176
Medford 142
Palermo 137
Des Moines 109
Nanjing 108
Princeton 88
Jacksonville 80
Milan 75
Boardman 70
Brussels 69
New York 58
Altamura 50
Seoul 48
Tulsa 41
Lawrence 40
Shenyang 40
Beijing 39
Dearborn 39
San Diego 37
Changsha 34
Santa Clara 32
Venice 32
Jinan 31
Nanchang 29
Hebei 28
Rome 26
Jiaxing 25
Verona 23
Abidjan 22
Tianjin 21
Tehran 20
Zhengzhou 20
Saint Petersburg 17
Seongnam 16
Brno 14
London 14
Naples 14
Ningbo 14
Washington 14
Falls Church 13
Florence 13
Giza 13
Helsinki 13
Kumar 13
Los Angeles 13
Ludwigshafen am Rhein 13
Munich 13
Toronto 13
Dallas 12
Haikou 12
Norwalk 12
Redwood City 12
Guangzhou 11
Hangzhou 11
Kraków 11
Phoenix 11
Amsterdam 10
Taizhou 10
Auburn Hills 9
Catania 9
New Delhi 9
Düsseldorf 8
Tabriz 8
Torino 8
Bologna 7
Kunming 7
Liverpool 7
Madrid 7
Mendicino 7
Napoli 7
San Paolo di Civitate 7
Tegucigalpa 7
Bremen 6
Buffalo 6
Cagliari 6
Hong Kong 6
Lanzhou 6
Pittsburgh 6
San Genesio Ed Uniti 6
Springfield 6
Taiyuan 6
Trento 6
Alcamo 5
Bandung 5
Cairo 5
Caserta 5
Ixelles-Elsene 5
Melbourne 5
Ribeirão Prêto 5
San Mateo 5
Totale 5.474
Salva come PNG Salva come JPEG
Nome #
Emotion recognition from facial expressions: a normative study of the Ekman 60-Faces Test in the Italian population. 360
Four cases of progressive multifocal leukoencephalopathy in iatrogenic immunocompromised patients 273
Quantitative EEG differentiate Multiple Sclerosis with and without Cognitive Impairment from healthy controls at the beginning of the disease: preliminary data 203
VDBP, CYP27B1, and 25-Hydroxyvitamin D Gene Polymorphism Analyses in a Group of Sicilian Multiple Sclerosis Patients 193
Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: A cohort study 190
The Ekman 60-faces test: an italiana normative study 172
Cardiovascular comorbidity in multiple sclerosis patients treated with mitoxantrone therapy: a cohort study 172
Sleep quality in caregivers of patients with Alzheimer’s disease and Parkinson’s disease and its relationship to quality of life 170
Klotho and vitamin D in multiple sclerosis: an Italian study 161
Anodal transcranial direct current stimulation over the right hemisphere improves auditory comprehension in a case of dementia 159
Effect of extracellular vesicles from CSF of multiple sclerosis patients and healthy controls on astrocytes in culture 157
Application of tRNS to improve multiple sclerosis fatigue: a pilot, single-blind, sham-controlled study 153
Neurofunctional correlates of attention rehabilitation in Parkinson's disease: an explorative study 141
A population-based survey of cognitive performance in a Sicilian elderly community. 139
Clinical features, disease course and prognosis in patients with paediatric and young adult onset multiple sclerosis 139
EARLY AND LATE MORTALITY OF SPONTANEOUS HEMORRHAGIC TRANSFORMATION OF ISCHEMIC STROKE 139
Anodal tDCS of the swallowing motor cortex for treatment of dysphagia in multiple sclerosis: a pilot open-label study 139
REM sleep behavior disorder in a patient with frontotemporal dementia 134
Lesion Load May Predict Long-Term Cognitive Dysfunction in Multiple Sclerosis Patients 134
Insidious onset of Pisa syndrome after rasagiline therapy in a patient with Parkinson’s disease 134
Quantitative EEG differentiates multiple sclerosis with and without cognitive impairment from healthy controls at the beginning of the disease: preliminary data 133
Social cognition dysfunctions in patients with epilepsy: Evidence from patients with temporal lobe and idiopathic generalized epilepsies. 130
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers 128
Differences in intercellular communication during clinical relapse and gadolinium-enhanced MRI in patients with relapsing remitting multiple sclerosis: A study of the composition of extracellular vesicles in cerebrospinal fluid 124
DYSAUTONOMIC DYSFUNCTION IN PARKINSON’DISEASE BY SCOPA-AUT SCALE 123
Extracellular vesicles isolated by cerebrospinal fluid as biomarkers of inflammation in multiple sclerosis and inflammatory neurological diseases. 117
Frontal dementia related to thalamic stroke: a case report. 110
Tumor diagnosis preceding Alzheimer's disease onset: is there a link between cancer and Alzheimer's disease? 108
Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab: Evidence From an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study). 102
Application of tRNS to improve Multiple Sclerosis Fatigue: a sham-controlled study 98
ELECTROCARDIOGRAPHIC FINDINGS IN PATIENTS WITH DEMENTIA. 97
PARKINSON’S DISEASE AND PARKINSON’S DISEASE FAMILIAL HISTORY. RESULTS OF A CASE-CONTROL STUDY 94
In patient’s with Parkinson disease, autonomic symptoms are frequent and associated with other non-motor symptoms 94
Rey-Osterrieth Complex figure performance in patients with degenerative dementia using Boston Qualitative Scoring System 92
Frequency of John Cunningham virus (JCV) DNA and of antibodies against JCV in patients affected by multiple sclerosis and their relationship with natalizumab therapy 90
Purine metabolism and Multiple Sclerosis: different pattern according to different disease stage and different clinical form. 89
Reversible Pisa Syndrome in a patient with Parkinson's Disease on rasagiline therapy 89
IMMUNOSUPPRESSANT TREATMENT AND CANCER RISK IN A COHORT OF PATIENTS AFFECTED BY MULTIPLE SCLEROSIS 88
Clinical and Instrumental Findings and Disability Progression in Primary Progressive and Progressive Relapsing Multiple Sclerosis: A Comparison Study of a Sicilian Group of Patients 87
Frequency of cognitive impairment and factors associated in outpatients with Parkinson’s disease 87
Clinical and instrumental predictors of efficacy of natalizumab therapy in the course of multiple sclerosis: a retrospective study from a single centre 87
Frequency and clinical features of progranulin mutation carriers in a series of patients affected by frontotemporal lobar de generation: report of a novel mutation 86
Thalamic stroke mimicking frontotemporal dementia: a case report 84
Toxic effects on astrocytes of extracellular vesicles from CSF of multiple sclerosis patients: A pilot in vitro study 83
PRIMARY PROGRESSIVE CROSSED APHASIA IN A DEXTRAL WOMAN 81
DYSAUTOMIC DISFUNCTON OCCURS EARLY IN PARKINSON DISEASE 81
Modulation of action tremor by repetitive transcranial magnetic stimulation in multiple sclerosis patients 80
Frequency of Mitoxantrone related heart involvement in patients affected by Multiple Sclerosis 78
EXTRACELLULAR VESICLES IN CEREBROSPINAL FLUID AS MARKERS OF CNS INFLAMMATION 76
Clinical features and disease out come in patients with pediatric and young adult onset Multiple Sclerosis 75
NEURODEGENERATION IN MULTIPLE SCLEROSIS: COMPARISON BETWEEN CLINICAL, NEUROPSYCHOLOGICAL, MRI,AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS 75
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 75
Quetiapine dose-sparing effect with addiction of memantine: two cases report of Lewy Body disease and dementia associated with Parkinson’s disease 74
INFLUENCE OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS) ON ACTION TREMOR IN MULTIPLE SCLEROSIS PATIENTS 73
Sleep and sleepiness in Parkinson’s disease: result of a “spontaneous” observational study on rotigotine 73
PREGNANCIES MODIFY RELAPSES AND PROGRESSION IN MULTIPLE SCLEROSIS 71
Chronic acquired hepatocerebral degeneration or Parkinson Disease? A case report 70
Pisa syndrome after rasagiline therapy in a patient with Parkinson’s disease 70
Heart involvement in patients treated with mitoxantrone for multiple sclerosis 69
Clinical and instrumental predictors of efficacy of Natalizumab therapy in multiple sclerosis patients: a retrospective study from a single centre 67
Emotion recognition in temporal lobe epilepsy and idiopathic generalized epilepsy 63
Sleep disturbances and dysautonomic dysfunction are associated in patients with Parkinson’s disease 63
Approccio multidimensionale ai disturbi non motori della Malattia di Parkinson 63
Return of disease activity after natalizumab therapy discontinuation in patients with multiple sclerosis: frequency and clinical and instrumental predictors of reactivation 61
Tumor diagnosis preceding Alzheimer’s disease: a case-control study 60
Identification of three novel progranulin mutations in a series of patients affected by sporadic and familial frontotemporal lobar de generation. Platform Presentation 59
Back to the life: a case of tretable dementia 58
Natalizumab therapy of relapsing-remitting multiple sclerosis: an evaluation of the safety profile and a comparison of efficacy with interferon beta therapy 56
Sleep quality in caregivers of Parkinson’s disease and Alzheimer’s disease patients and its relationship to quality of life 55
COGNITIVE IMPAIRMENT IN PATIENTS WITH PARKINSON’S DISEASE 55
RISK FACTORS FOR DYSKINESIAS IN PATIENTS WITH PARKINSON'S DISEASE 54
Urinary dysfunction in Parkinson’s disease patients 54
Multiple reversibile MR signals in course of Epstein-Barr virus encephalitis 53
Clinical Features and disease outcome in pt with pediatric and young adult onset multiple sclerosis 51
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 50
Primary Progressive and progressive relapsing multiple sclerosis show different clinical and instrumental findings and disability progression? A comparison study on a Sicilian database 50
Mitochondrial DNA TRNACYS mutation in a family with frontotemporal dementia and Parkinson’s disease 49
Primary progressive crossed aphasia in dextrals: report of three cases 49
Natalizumab Discontinuation after the 24th Course: Which Is Way? The TY-STOP Study 48
Psychosis as adverse effect of cholinesterase inhibitors: two case reports of probable Alzheimer disease in treatment with galantamine 47
Computer-assisted cognitive remediation for Parkinson’s disease 46
EMpathy ability and emotion recognition in temporal lobe epilepsy and idhiopathic generalizede epileps 46
null 44
Reduced striatal dopamine transporter binding in posterior cortical atrophy 40
Looking for the best therapeutical stretegy after the 24th natalizumab adiministretion. The TY-STOP study 39
null 38
null 37
LATE MORTALITY OF HEMORRHAGIC TRANSFORMATION OF ISCHEMIC STROKE 37
Treatment of multiple sclerosis patients after 24 Natalizumab doses: a prospective observational study: the TY-STOP 33
TREATMENT CHOICE AFTER 24 NATALIZUMAB DOSES IN PATIENTS WITH MULTIPLE SCLEROSIS: A PROSPECTIVE OBSERVATIONAL STUDY, THE TY-STOP 26
Discontinuation of treatment with Natalizumab after 24 courses. Report from spontaneous, observational, prospective study (TYSTOP). 26
Lifestyle factors and multiple sclerosis: a case control study 23
Purine metabolism and multiple sclerosis: pattern varies according to disease stage and clinical form 19
null 3
Totale 8.625
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.985
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.985
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.113 0 0 0 0 137 181 142 118 121 67 201 146
2020/20211.120 125 150 42 142 70 40 88 74 136 85 56 112
2021/2022963 49 205 40 47 31 43 31 64 105 110 45 193
2022/20231.600 149 184 51 154 278 257 97 129 181 18 84 18
2023/2024828 38 122 40 82 78 143 44 63 17 46 27 128
2024/2025531 63 97 92 174 105 0 0 0 0 0 0 0
Totale 8.625